Jun 30
|
BofA Remains Bullish on Argenx (ARGX) With a Buy Rating and $804 PT
|
Jun 30
|
argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes
|
Jun 26
|
High Growth Tech Stocks In Europe To Watch June 2025
|
Jun 26
|
Exploring High Growth Tech Stocks In Europe June 2025
|
Jun 25
|
High Growth Tech Stocks In Europe Featuring Ubisoft Entertainment And Two Others
|
Jun 20
|
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
|
Jun 18
|
High Growth Tech Stocks in Europe for June 2025
|
Jun 18
|
High Growth Tech Stocks In Europe To Watch
|
Jun 10
|
argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
|
Jun 9
|
High Growth Tech Stocks To Watch In Europe June 2025
|
Jun 6
|
This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues
|
Jan 30
|
Exploring High Growth Tech Stocks With Promising Potential
|